Filing Flows › 8-K events › Borealis Foods
Borealis Foods: departure or appointment of directors and officers
Form 8-K filed Nov 4, 2026 · items 3.01, 5.02, 8.01
What the filing says
On October 29, 2026, Pavel Mynzhanov notified the Company of his resignation as a member of the Board, effective the same day. Mynzhanov’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
Read the filing on SEC EDGAR →
What usually followsAcross 492 8-Ks reporting Item 3.01 (delisting notice or listing-rule failure) in our universe, the stock's median move the next session was 0.0% (typical size ±2.1%, up 46% of the time); over the following 21 sessions, −0.2%. Item 5.02: −0.1% next session across 39,174. Item 8.01: +0.1% next session across 44,881. Every item ranked →
What this kind of filing means
Item 3.01 — Notice of delisting or failure to meet a listing standard. A delisting notice starts a compliance window; companies often answer with a reverse split, a plan, or a move to another market.
Item 5.02 — Departure or appointment of directors and officers. Leadership changes: who leaves, who arrives and on what terms. A sudden CEO or CFO departure without a successor deserves attention.
Borealis Foods at a glance
Borealis Foods, Q1 2026: revenue $7.8M (+8% year over year), operating margin -26.5%. The chart follows the revenue to costs, profit and cash.
Borealis Foods: every quarter, Q/Q and Y/Y, holders and guidance →
Other recent delisting notices
- Barfresh Food Group Nov 6, 2026
- Fifth Era Acquisition Corp I Nov 6, 2026
- Tempest Therapeutics Nov 6, 2026
- Roku Nov 6, 2026
- Bowman Consulting Group Nov 6, 2026
- Knightscope Nov 6, 2026
- Curis Nov 6, 2026
- Intrusion Nov 5, 2026
- Karyopharm Therapeutics Nov 5, 2026
- Cognition Therapeutics Nov 5, 2026
Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.